Expression and aberrant promoter methylation of Wnt inhibitory factor-1 in human astrocytomas

Table 1 Patient's clinical data and results of our study

Sample	Sex	Age	WHO grade	IHC scores	mRNA	Methylation status
N1	F	60		7	0.927	U
N2	F	56		7	0.907	U
N3	M	28		7	0.862	U
N4	M	56		8	0.976	U
N5	F	27		8	0.915	U
N6	M	57		7	0.791	U
T1	M	43	II	2	0.107	U/M
T2	F	50	III	0	0	M
T3	F	38	II	5	0.653	U
T4	M	34	III	0	0	M
T5	F	57	II	2	0.658	U
T6	M	61	III	5	0.773	U
T7	M	54	IV	5	0.602	U/M
T8	M	66	IV	1	0	M
T9	F	14	I	7	0.809	U
T10	F	40	II	2	0.151	M
T11	M	37	II	5	0.462	U
T12	M	43	II	3	0.769	U
T13	F	53	II	5	0.398	U
T14	M	27	II	5	0.716	U
T15	M	45	II	5	0.722	U
T16	F	45	IV	1	0.115	M
T17	F	39	III	6	0.897	U
T18	M	30	II	3	0.215	M
T19	M	40	IV	0	0.000	M
T20	F	33	II	5	0.704	U
T21	F	38	IV	0	0.000	M
T22	M	5	II	7	0.907	U
T23	M	51	IV	1	0.000	M
T24	M	66	II	5	0.478	U
T25	F	46	II	5	0.447	U
T26	M	55	III	1	0.134	U/M
T27	M	41	III	1	0.153	U/M
T28	M	43	IV	2	0.153	M
T29	F	39	IV	1	0.129	M
T30	M	29	IV	5	0.347	U
T31	M	16	IV	0	0.000	M
T32	F	55	IV	1	0.147	M
T33	M	58	IV	2	0.189	U/M
T34	F	27	IV	1	0.131	M
T35	M	58	IV	1	0.182	M
T36	M	50	IV	3	0.122	M
T37	M	14	IV	2	0.337	U/M
T38	F	9	IV	4	0.334	U
T39	M	33	III	3	0.247	U/M
T40	F	19	III	5	0.783	U
T41	M	33	II	1	0.179	M
T42	M	38	II	2	0.164	M
T43	M	63	II	1	0.293	U/M
T44	F	37	III	2	0.158	M
T45	F	11	III	0	0.000	M
T46	M	27	III	5	0.523	U
T47	F	23	IV	3	0.467	U
T48	M	27	II	0	0.176	U/M
T49	F	28	II	6	0.828	U
T50	M	25	II	2	0.332	U
T51	M	40	II	8	0.903	U
T52	M	38	II	5	0.443	U
T53	F	48	III	4	0.324	U

N, normal brain tissue; T, astrocytoma tissue ;M, male; F, female; IHC, immunohistochemistry; U, unmethylation; M, methylation

ISSN: 1756-9966